New studies show that treatments targeting specific viral genes protected monkeys infected with deadly Ebola or Marburg viruses. Furthermore, the animals were protected even when therapeutics were administered one hour after exposure -- suggesting the approach holds promise for treating accidental infections in laboratory or hospital settings.